Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
Authors:
Open Access
- 16 November 2009
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 29 (6) , 920-929
Abstract
Signal transducer and activator of transcription 1 (STAT1) is activated in the inflammatory response to interferons. The MUC1 oncoprotein is overexpressed in human breast cancers. Analysis of genes differentially expressed in MUC1-transformed cells has identified a network linking MUC1 and STAT1 that is associated with cellular growth and inflammation. The results further show that the MUC1-C subunit associates with STAT1 in cells and the MUC1-C cytoplasmic domain binds directly to the STAT1 DNA-binding domain. The interaction between MUC1-C and STAT1 is inducible by IFNγ in non-malignant epithelial cells and constitutive in breast cancer cells. Moreover, the MUC1–STAT1 interaction contributes to the activation of STAT1 target genes, including MUC1 itself. Analysis of two independent databases showed that MUC1 and STAT1 are coexpressed in about 15% of primary human breast tumors. Coexpression of MUC1 and the STAT1 pathway was found to be significantly associated with decreased recurrence-free and overall survival. These findings indicate that (i) MUC1 and STAT1 function in an auto-inductive loop, and (ii) activation of both MUC1 and the STAT1 pathway in breast tumors confers a poor prognosis for patients.Keywords
This publication has 46 references indexed in Scilit:
- MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor-κB p65 Transcription FactorCancer Research, 2009
- MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatmentProceedings of the National Academy of Sciences, 2009
- MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung CancerCancer Research, 2009
- A phosphorylation-acetylation switch regulates STAT1 signalingGenes & Development, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences, 2008
- A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast CancerClinical Cancer Research, 2008
- MUC1 oncoprotein blocks nuclear targeting of c‐Abl in the apoptotic response to DNA damageThe EMBO Journal, 2006
- Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucinNature Structural & Molecular Biology, 2005
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001